Internal Medicine, Hematology & Oncology · Dallas, TX
NPI
1942424528
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
6201 Harry Hines Blvd Mail Code 8565
Dallas, TX, 75390
Phone (214) 645-4673
Groups this clinician bills Medicare through
Medicare paid, 2024
$68K
790 services
Medicare patients, 2024
290
Average age 74
Drug cost, 2024
$6.0M
2,066 prescriptions
Company payments, 2025
$16K
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Farrukh T Awan was code 99215 (office e&m - established), 204 times for 106 patients. In total Farrukh T Awan billed 790 services in 15 codes, and Medicare paid $68K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-11-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 204 | 106 | $111.63 | $23K |
| 99233 Hospital E&M - Subsequent | Facility | 112 | 26 | $91.78 | $10K |
| 99215 Office E&M - Established | Office | 107 | 68 | $94.74 | $10K |
| 99214 Office E&M - Established | Office | 94 | 76 | $70.68 | $6,644 |
| 99214 Office E&M - Established | Facility | 87 | 76 | $73.43 | $6,388 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 47 | 41 | $12.64 | $594 |
| 99205 Office E&M - New | Facility | 22 | 22 | $141.16 | $3,106 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 19 | 13 | $12.83 | $244 |
| 99213 Office E&M - Established | Office | 18 | 17 | $47.54 | $856 |
| 99223 Hospital E&M - Initial | Facility | 15 | 15 | $129.83 | $1,947 |
| 99205 Office E&M - New | Office | 15 | 15 | $121.01 | $1,815 |
| 99213 Office E&M - Established | Facility | 13 | 13 | $47.35 | $616 |
By year: 2022 $91K for 1,027 services; 2023 $58K for 699 services; 2024 $68K for 790 services.
Medicare prescription drug claims, 2024
In 2024, the drug Farrukh T Awan prescribed most often to Medicare patients was Acyclovir, with 488 prescriptions and refills. In total Farrukh T Awan wrote 2,066 Medicare prescriptions that cost $6.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 488 | 773 | 112 | $7,088 |
| Calquence Acalabrutinib Maleate | 284 | 284 | 36 | $4.0M |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 175 | 232 | 48 | $878 |
| Allopurinol Generic | 169 | 291 | 68 | $1,558 |
| Levofloxacin Generic | 66 | 66 | 50 | $337 |
| Prednisone Generic | 60 | 74 | 28 | $269 |
| Methylprednisolone Generic | 55 | 55 | 51 | $346 |
| Ondansetron Hcl Generic | 48 | 48 | 37 | $361 |
| Valacyclovir Valacyclovir Hcl | 40 | 76 | Under 11 | $1,569 |
| Gabapentin Generic | 39 | 67 | 15 | $440 |
| Prochlorperazine Maleate Generic | 34 | 34 | 30 | $384 |
| Imbruvica Ibrutinib | 33 | 33 | Under 11 | $515K |
| Fluconazole Generic | 28 | 30 | 13 | $658 |
| Venclexta Venetoclax | 27 | 27 | Under 11 | $378K |
| Lorazepam Generic | 25 | 25 | 25 | $15.23 |
Brand drugs: - claims; generic drugs: 1,598 claims; opioid claims: 22.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Farrukh T Awan $16K ($15K in general payments such as food, travel and fees and $1,703 for research) from 12 companies. The largest payer was BeiGene USA, Inc. with $5,518.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.